In this episode, Elle Russ chats with Dr. Gary E. Foresman MD to unpack the science, hype, and controversy surrounding GLP-1-based weight loss medications like Ozempic, Wegovy, Mounjaro, and peptides.

Dr. Foresman explores how these drugs actually work—from appetite suppression to metabolic effects—and who’s a good candidate (and who should avoid them). The conversation tackles the real benefits and the real risks beyond the headlines - breaks down the differences between peptides and FDA-approved medications, and examines the big question: Is the weight loss sustainable long-term? We also dive into practical concerns like cost, accessibility, and alternatives for those seeking options outside this class of drugs.

Whether you’re considering these medications, curious about the science, or just tired of the hype, this conversation cuts through the noise with an honest, no-industry-spin look at one of the biggest health trends of our time.

Article mentioned in this episode:

https://www.middlepathmedicine.com/blogs/new-2024-articles-teachings/tirzepatide-the-time-has-come

 

FREEBIES:

Free Thyroid Guide + Video Series: https://www.elleruss.com/thyroid-guide

Free Confidence eBook & Workbook: https://www.elleruss.com/7secrets

Elle's newsletter: https://www.elleruss.com/newletter

 

GUEST LINKS:

https://www.middlepathmedicine.com/